An Alzheimer’s re­jec­tion; Our #JPM23 dis­patch­es; Count Mod­er­na in for RSV; Biotech lay­offs per­sist; and more

3 years ago
Weekly

Sanofi, Ab­b­Vie, MSD pledge with Pub­li­cis and con­sumer brand co­hort to end can­cer stig­ma at work

3 years ago
Pharma
Marketing

UK's NICE stamps ap­proval on Al­ny­lam, PTC rare dis­ease drugs

3 years ago
Pharma

Next-gen mpox treat­ments: FDA calls for di­verse, ran­dom­ized con­trolled tri­als

3 years ago
FDA+

Sanofi promis­es mon­ey back for dis­con­tin­ued blood dis­or­der treat­ment – in some cas­es

3 years ago
Pharma

Is­rael, EU drug reg­u­la­tors find no link be­tween Pfiz­er Covid shot and stroke

3 years ago
R&D
Coronavirus

As­traZeneca ex­pands chron­ic kid­ney dis­ease 'Tar­get' cam­paign for Farx­i­ga

3 years ago
Pharma
Marketing

'Blue Brain Boost': FDA blocks Col­orado cou­ple from im­port­ing and re­selling drugs from Chi­na

3 years ago
FDA+

Fed­er­al judge up­holds Cabome­tyx patent in Ex­elix­is' gener­ic bat­tle

3 years ago
Pharma
Law

Mar­tin Shkre­li is back in the crosshairs of the fed­er­al gov­ern­ment for not stay­ing out of phar­ma

3 years ago
Pharma
Law

How small can you ‘om­ic? New start­up wants to pro­file the tiny space be­tween neu­rons to study Alzheimer’s

3 years ago
R&D

FDA lifts clin­i­cal hold on Astel­las’ Pompe gene ther­a­py

3 years ago
Cell/Gene Tx
FDA+

Seagen's Tukysa la­bel ex­pand­ed; ADARx gets $46M script for RNA tri­al

3 years ago
News Briefing

Sesen takes next step af­ter in­vestor at­tack, calls for share­hold­er vote to ap­prove merg­er

3 years ago
Financing
Deals

Ipsen's pan­cre­at­ic can­cer drug bests decade-old stan­dard of care

3 years ago
R&D
Pharma

Disc Med­i­cine pays $10M up­front for mon­o­clon­al an­ti­body for rare blood dis­or­der, can­cer

3 years ago
Deals

As monother­a­py da­ta dis­ap­point, Cyteir lets go of 35 staffers, goes all in on ovar­i­an can­cer

3 years ago
People

Scoop: Just months af­ter Sanofi AI deal, Atom­wise laid off 30% of staffers amid 's­trate­gic shift'

3 years ago
People

#JPM23 with Robert Nelsen: Our mot­to is 'do cool s@*t'

3 years ago

'Per­fect time': SIGA's CEO on re­tire­ment; Ju­ve­nes­cence woos GSK vet to lead an­ti-ag­ing play

3 years ago
Peer Review

BeiGene's Brukin­sa wins CLL ap­proval af­ter top­ping Im­bru­vi­ca in head-to-head tri­al

3 years ago
China
Pharma

FDA squash­es ac­cel­er­at­ed hopes for Eli Lil­ly’s Alzheimer’s drug as agency asks for more da­ta

3 years ago
R&D
Pharma

Urovant taps celebri­ty ad­vo­cate and pa­tient Hol­ly Robin­son Peete for over­ac­tive blad­der ed­u­ca­tion

3 years ago
Pharma
Marketing

New clin­i­cal tri­al sys­tem to soon be­come manda­to­ry in Eu­rope

3 years ago
Pharma
FDA+
First page Previous page 399400401402403404405 Next page Last page
A service from the Financial Times